All In MedTech

Device Trial Radar · NCT05862558

Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR

Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Mar 30, 2023

Primary completion

Oct 1, 2026

Study completion Oct 1, 2027

Sponsor

Lead sponsor
Baylor Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Shockwave Medical, Inc.
First posted
May 17, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the efficacy and safety of Intravascular Lithotripsy (IVL) in subjects undergoing transfemoral TAVR in patients with severe iliac disease, prohibitive for transfemoral TAVR in patients with severe symptomatic aortic stenosis, otherwise considered for alternative access TAVR. (e.g. trans-carotid)

Conditions

  • Iliac Disease
  • Aortic Valve Stenosis

Interventions

  • Shockwave BalloonDevice

    Intravascular lithotripsy (IVL) performed with the Shockwave balloon (Shockwave Medical Inc) enables treatment of calcified stenosis of the peripheral arteries by using sonic pressure waves to selectively disrupt superficial and deep calcium without impacting healthy tissue

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Acute technical success per the DISRUPT PAD definition at the time of interventionTime frame: At time of IVL procedure
  2. Success rate of transfemoral delivery of a TAVR system post IVL within 30 days of treatmentTime frame: At the time of TAVR procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Baylor Scott and White Heart Hospital

    Plano, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.